APA (7th ed.) Citation

Gbadamosi, M. O., Molchan, E., Makarem, M. S., Coleman, K. L., Ohaegbulam, A. C., & Streeks, K. H. (2025). Chemoimmunomodulation in triple negative breast cancer: A key to maximizing anti-PD-1 chemoimmunotherapeutic efficacy. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Gbadamosi, Mohammed O., Elizabeth Molchan, Mariana S. Makarem, Kennedy L. Coleman, Alyssa C. Ohaegbulam, and Kathleen H. Streeks. Chemoimmunomodulation in Triple Negative Breast Cancer: A Key to Maximizing Anti-PD-1 Chemoimmunotherapeutic Efficacy. Taylor & Francis Group, 2025.

MLA (9th ed.) Citation

Gbadamosi, Mohammed O., et al. Chemoimmunomodulation in Triple Negative Breast Cancer: A Key to Maximizing Anti-PD-1 Chemoimmunotherapeutic Efficacy. Taylor & Francis Group, 2025.